Autografting for CML--where does it fit in to the overall treatment strategy?
Goldman
J M
JM
Royal Postgraduate Medical School, London, UK.
D016026:Bone Marrow Transplantation; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D014182:Transplantation, Autologous
D016898:Interferon-alpha